Industry

An All-New Docuseries from Executive Producers Jeannie Mai, Alyssa Milano, and Award-Winning Filmmakers Sadhvi Siddhali Shree and Sadhvi Anubhuti NEW YORK–(BUSINESS WIRE)–Tellory sponsored a luncheon in celebration of the premiere of Balance: A Perimenopause Journey, a new docuseries produced by Jeannie Mai and Alyssa Milano that explores the often misunderstood and under-discussed realities of perimenopause. … [Read more…]

CHICAGO–(BUSINESS WIRE)–Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan to December 31, 2026 (the “Rights Plan”). The Board’s decision to extend the Rights Plan is based on … [Read more…]

Susan G. Komen® Applauds Bill Introduction, Urges Quick Passage HONOLULU–(BUSINESS WIRE)–Susan G. Komen®, the world’s leading breast cancer organization commends Representative Lauren Matsuomto (R-Mililani) introducing legislation to ensure equitable access to required diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening. The exorbitant out-of-pocket costs associated … [Read more…]

Deal enhances existing value, evidence, and market access solutions as demand for economic and outcomes services accelerates YARDLEY, Pa.–(BUSINESS WIRE)–Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access, commercial, and learning & development, today announced that it has acquired Bridge Medical Consulting, a specialized health economics and outcomes … [Read more…]

Search Committee Has Initiated a Global Search to Select Next CEO LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors (the “Board”) has appointed Warren Foust, … [Read more…]

Service ensures that clinicians are properly qualified, consistently trained and monitored throughout the life of a trial MAIDENHEAD, England–(BUSINESS WIRE)–RWS (RWS.L), a global AI solutions company, announces the launch of a new rater training, certification and retraining service designed specifically to improve data quality, consistency and reliability in central nervous system (CNS) clinical trials. The … [Read more…]

The United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe glabellar lines (frown lines) and lateral canthal lines (crow’s feet) in adults RelabotulinumtoxinA is designed to optimize molecule integrity to deliver fast onset of action as early as Day 1 … [Read more…]

NEW YORK–(BUSINESS WIRE)–Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the appointment of Paul Abrams as Vice President of Sales. Abrams will oversee the company’s commercial strategy and execution as Vent Creativity expands adoption of its digital twin platform for orthopedic surgery. Vent Creativity’s software enables surgeons to create a patient-specific … [Read more…]

PARIS–(BUSINESS WIRE)–#AntiAging—Lorient, a premium aesthetic brand, announced that it has drawn global attention at the 27th IMCAS World Congress 2026 in Paris, attracting over 15,000 professionals and demonstrating its leadership in aesthetic innovation. The highlight was a session led by Dr. Jani van Loghem, a globally revered key opinion leader known for establishing international aesthetic … [Read more…]

First-ever approved treatment for CDD in China now set for commercial launch through dedicated rare disease platform SHANGHAI–(BUSINESS WIRE)–Tenacia Biopharmaceuticals (Shanghai) Co., Ltd. (“Tenacia“) and GOLDEN AGE HEALTH (SHANGHAI) CO., LTD., a subsidiary of Golden Age Health Pte. Ltd. (collectively, “GAH“) today announced a Commercialization Agreement granting GAH exclusive rights to commercialize ZTALMY® (泽元安), the … [Read more…]